Influence of the non-competitive NMDA receptor antagonist MK-801 on 2-deoxy-d-glucose-induced hyperphagia in rats

By Sugimoto Y.   Yamada J.   Yoshikawa T.  

European Journal of Pharmacology, Vol. 378, Iss. 2, 1999-08 ,pp. : 149-152

Elsevier

Access to resources Recommend Favorite

Systemic administration of the NMDA receptor antagonist MK-801 potentiates circling induced by intrastriatal microinjection of dopamine

By St-Pierre J.-A.   Bedard P.J.  

European Journal of Pharmacology, Vol. 272, Iss. 2, 1995-01 ,pp. : 123-129

Elsevier

Access to resources Recommend Favorite

Molsidomine potentiates the protective activity of GYKI 52466, a non-NMDA antagonist, MK-801, a non-competitive NMDA antagonist, and riluzole against electroconvulsions in mice

By Tutka P.   Olszewski K.   Wozniak M.   Kleinrok Z.   Czuczwar S.J.   Wielosz M.  

European Neuropsychopharmacology, Vol. 12, Iss. 4, 2002-08 ,pp. : 321-326

Elsevier

Access to resources Recommend Favorite

NMDA receptors and behavioural sensitization: beyond dizocilpine

By Wolf M.E.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 5, 1999-05 ,pp. : 188-189

Elsevier

Access to resources Recommend Favorite

Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats

By Abekawa Tomohiro   Ito Koki   Nakagawa Shin   Koyama Tsukasa  

Psychopharmacology, Vol. 192, Iss. 3, 2007-06 ,pp. : 303-316

Springer Publishing Company

Access to resources Recommend Favorite